HomeCompareESALF vs JEPI

ESALF vs JEPI: Dividend Comparison 2026

ESALF yields 3.60% · JEPI yields 8.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPI wins by $3.6K in total portfolio value
10 years
ESALF
ESALF
● Live price
3.60%
Share price
$30.00
Annual div
$1.08
5Y div CAGR
0.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$474.23
Full ESALF calculator →
JEPI
JPMorgan Equity Premium Income ETF
● Live price
8.40%
Share price
$56.68
Annual div
$4.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$1,528.62
Full JEPI calculator →

Portfolio growth — ESALF vs JEPI

📍 JEPI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESALFJEPI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESALF + JEPI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESALF pays
JEPI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESALF
Annual income on $10K today (after 15% tax)
$306.00/yr
After 10yr DRIP, annual income (after tax)
$403.10/yr
JEPI
Annual income on $10K today (after 15% tax)
$714.16/yr
After 10yr DRIP, annual income (after tax)
$1,299.33/yr
At 15% tax rate, JEPI beats the other by $896.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESALF + JEPI for your $10,000?

ESALF: 50%JEPI: 50%
100% JEPI50/50100% ESALF
Portfolio after 10yr
$27.2K
Annual income
$1,001.42/yr
Blended yield
3.68%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESALF buys
0
JEPI buys
0
No recent congressional trades found for ESALF or JEPI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESALFJEPI
Forward yield3.60%8.40%
Annual dividend / share$1.08$4.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.4%0%
Portfolio after 10y$25.4K$29.0K
Annual income after 10y$474.23$1,528.62
Total dividends collected$4.2K$11.7K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: ESALF vs JEPI ($10,000, DRIP)

YearESALF PortfolioESALF Income/yrJEPI PortfolioJEPI Income/yrGap
1← crossover$11,061$361.44$11,260$840.19$199.00JEPI
2$12,211$375.14$12,641$907.94$430.00JEPI
3$13,454$388.58$14,150$978.20$696.00JEPI
4$14,798$401.74$15,795$1,050.85$997.00JEPI
5$16,248$414.60$17,584$1,125.74$1.3KJEPI
6$17,813$427.16$19,526$1,202.74$1.7KJEPI
7$19,499$439.41$21,628$1,281.69$2.1KJEPI
8$21,315$451.34$23,898$1,362.43$2.6KJEPI
9$23,270$462.94$26,347$1,444.79$3.1KJEPI
10$25,373$474.23$28,982$1,528.62$3.6KJEPI

ESALF vs JEPI: Complete Analysis 2026

ESALFStock

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Full ESALF Calculator →

JEPIETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →
📬

Get this ESALF vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESALF vs SCHDESALF vs OESALF vs KOESALF vs MAINESALF vs JEPQESALF vs XYLDESALF vs DIVOESALF vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.